NCBI-Aggregator

  • Electroconvulsive therapy in a patient with Huntington's disease and depression: a case-report
    Tijdschr Psychiatr. 2026;68(2):82-85.ABSTRACTWe present the case of a 60-year-old woman with Huntington’s disease who was successfully treated with electroconvulsive therapy (ECT) for a recurrent depressive disorder presenting with acute suicidality. Depression is the most common neuropsychiatric disorder in Huntington’s disease and ranks among the most important risk factors for suicide...Read more
    Source: NCBI Date: 2026-02-23 By S van Meerbeeck
  • Ubiquitin ligase Nedd4 regulates the abundance and toxicity of mutant huntingtin
    JCI Insight. 2026 Feb 23;11(4):e181013. doi: 10.1172/jci.insight.181013. eCollection 2026 Feb 23.ABSTRACTHuntington's disease (HD) is a neurodegenerative disorder caused by the expansion of CAG repeats in the gene encoding huntingtin. Since accumulation of mutant huntingtin (mHtt) leads to dysfunction of numerous cellular pathways and toxicity, reducing levels of the mutant protein...Read more
    Source: NCBI Date: 2026-02-22 By Hyunkyung Jeong
  • Differences in white matter detected by ex vivo 9.4 T MRI are associated with axonal changes in the R6/1 model of Huntington's disease
    Neurobiol Dis. 2026 Mar;220:107318. doi: 10.1016/j.nbd.2026.107318. Epub 2026 Feb 11.ABSTRACTWhite matter volume loss has been reported as one of the first indicators in Huntington's disease (HD) patients, but the cellular basis of this deficit remains to be elucidated. To address this, we assessed white matter microstructure in the transgenic R6/1...Read more
    Source: NCBI Date: 2026-02-12 By C Casella
  • Decreased Physical Activity as an Early Digital Biomarker in Huntington's Disease: A One-Year Observational Study
    Brain Behav. 2026 Feb;16(2):e71149. doi: 10.1002/brb3.71149.ABSTRACTINTRODUCTION: Huntington's disease (HD) is a neurodegenerative disorder characterised by motor dysfunction, cognitive impairment, and psychiatric disturbances. This study analyzed the relationship between clinical characteristics, sarcopenia, and physical activity (PA) levels in HD patients.METHODS: A 1-year observational study was conducted with symptomatic, ambulatory HD patients,...Read more
    Source: NCBI Date: 2026-02-05 By Lucía Simón-Vicente
  • Co-Design of a New Integrated Care Model With People Affected by Huntington's Disease: A Mixed Methods Study
    Health Expect. 2026 Feb;29(1):e70584. doi: 10.1111/hex.70584.ABSTRACTBACKGROUND: People living with neurological conditions have needs that require an integrated care approach. Existing models of integrated care have often emphasized system structures but neglected the micro-level interactions that matter most to people.OBJECTIVES: To develop a micro-level model for integrated care that represents the...Read more
    Source: NCBI Date: 2026-01-31 By Sandra Bartolomeu Pires
  • Executive Impairment in Huntington's Disease: Insights From a Systematic Review of the Literature
    Brain Behav. 2026 Feb;16(2):e71238. doi: 10.1002/brb3.71238.ABSTRACTPURPOSE: This systematic review examines executive dysfunction in Huntington's disease (HD), an inherited neurodegenerative disorder characterized by cognitive alterations that may emerge years before the onset of motor symptoms. The objective of this review is to provide an updated and comprehensive synthesis of executive function...Read more
    Source: NCBI Date: 2026-01-30 By Simone Migliore
  • Exploring huntington's disease from a neurodevelopmental perspective
    Int J Biol Sci. 2026 Jan 1;22(3):1233-1246. doi: 10.7150/ijbs.124552. eCollection 2026.ABSTRACTHuntington's disease (HD) is a rare, inherited neurodegenerative disorder caused by mutations in the huntingtin (HTT) gene. The classic concept is that HD is a degenerative disease that primarily affects the striatum, caused by a gain-of-function mutant mHTT that kills...Read more
    Source: NCBI Date: 2026-01-28 By Chunhui Huang
  • Non-Directiveness and Authenticity in the Predictive Genetic Clinic
    Sociol Health Illn. 2026 Feb;48(2):e70149. doi: 10.1111/1467-9566.70149.ABSTRACTThe predictive genetic clinic is a space where counsellors use non-directive counselling to facilitate asymptomatic patients at risk of carrying a dominantly inherited disease access a predictive genetic test. The social science literature has a history of examining practices within this clinic, but with...Read more
    Source: NCBI Date: 2026-01-28 By Shane Doheny
  • From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease
    Drug Dev Res. 2026 Apr;87(2):e70238. doi: 10.1002/ddr.70238.ABSTRACTHuntington's disease (HD) is a progressive neurodegenerative disorder with a poorly understood neurobiological basis. Among the various forms of programmed cell death implicated in neurodegeneration, necroptosis has recently garnered significant attention. Notably, dysregulated necroptosis provokes immune response that drives excessive pro-inflammatory cytokine production, promoting...Read more
    Source: NCBI Date: 2026-01-26 By Muhammad A Eltarzy
  • Shape matters: Predicting Huntington's disease using progression modelling
    Comput Methods Programs Biomed. 2026 Apr;277:109250. doi: 10.1016/j.cmpb.2026.109250. Epub 2026 Jan 15.ABSTRACTBACKGROUND: Despite evidence of group-level differences in striatal morphometry among persons with Huntington's Disease (PwHD), current models of HD progression used for participant selection and assessment of treatment outcomes in clinical trials do not leverage shape information.METHODS: We first...Read more
    Source: NCBI Date: 2026-01-20 By Mohsen Ghofrani-Jahromi
  • Decoding Non-Neuronal Mechanisms and Therapeutic Targets in Huntington's Disease Through Integrative Transcriptomics and Machine Learning
    J Mol Neurosci. 2026 Jan 19;76(1):11. doi: 10.1007/s12031-025-02463-z.ABSTRACTHuntington's disease (HD) is a rare, inherited neurodegenerative disorder caused by the expanded CAG repeats in the huntingtin gene. The HD domain still lacks detailed knowledge of validated drug targets, limiting the effectiveness of classical methods. To address this gap, we have applied...Read more
    Source: NCBI Date: 2026-01-18 By Himanshi Gupta
  • Astrocytic noncanonical WNT5B signaling modulates extracellular matrix remodeling and neuropathology in Huntington's disease
    Signal Transduct Target Ther. 2026 Jan 19;11(1):23. doi: 10.1038/s41392-025-02545-9.ABSTRACTHuntington's disease (HD) is a fatal neurodegenerative disorder characterized by a triad of behavioral symptoms: involuntary movement, emotional change, and cognitive dysfunction. Although alterations in WNT signaling have been reported in HD, its precise role in pathogenesis remains unclear. In this study,...Read more
    Source: NCBI Date: 2026-01-17 By Phuong Thi Thanh Nguyen
  • Discovery of disrupted sustained attention and altered functional connectivity in far-from-onset Huntington's disease gene-expanded young adults
    Alzheimers Dement. 2026 Jan;22(1):e70944. doi: 10.1002/alz.70944.ABSTRACTBACKGROUND: Cognitive impairments are a hallmark of Huntington's disease (HD).METHODS: Seventy-one participants (43 HD gene-expanded [HDGE], 28 healthy controls) from the HD-Young Adult Study at two timepoints ≈ 4.7 years apart, completed the Cambridge Neuropsychological Test Automated Battery Rapid Visual Information Processing task and underwent...Read more
    Source: NCBI Date: 2026-01-12 By Christelle Langley
  • Eye manifestations in Huntington's disease: an update on the potential of ocular biomarkers
    J Neurol. 2026 Jan 8;273(1):68. doi: 10.1007/s00415-025-13600-4.ABSTRACTHuntington's disease (HD) remains a devastating neurodegenerative disorder caused by CAG repeat expansion in the HTT gene. Biomarkers are urgently needed to facilitate more accurate evaluation of disease onset, progression, and response to interventions. Characteristic clinical features of the disease are secondary to neuronal...Read more
    Source: NCBI Date: 2026-01-07 By William A Woods
  • Programmed cell death pathways in huntington's disease: spotlight on ferroptosis and pyroptosis
    Neurol Sci. 2026 Jan 2;47(1):83. doi: 10.1007/s10072-025-08689-4.ABSTRACTHuntington's disease (HD) is characterized by dementia, delayed psychomotor processes, abnormal choreatic movements, and cognitive impairments. This condition is brought on by an increase in cytosine-adenine-guanine repeats in the huntingtin (Htt) gene on chromosome-4, which produces the Htt protein's poly-glutamine (poly-Q). Despite significant progress...Read more
    Source: NCBI Date: 2026-01-02 By Veerta Sharma